Bone mass and subtle abnormalities in ovulatory function in healthy women

Area of Science:

• Reproductive Endocrinology
• Bone Metabolism
• Women's Health

Background:

• Luteal phase abnormalities in menstrual cycles have been anecdotally linked to accelerated bone mineral density (BMD) loss.
• Previous reports suggest a potential association between ovulatory dysfunction and decreased bone health.

Purpose of the Study:

• To longitudinally investigate the association between luteal phase abnormalities and bone mineral density (BMD) changes in healthy premenopausal women.
• To determine if menstrual cycle irregularities correlate with accelerated bone loss.

Main Methods:

• A longitudinal study involving 53 healthy premenopausal women who provided daily urine samples for hormone metabolite analysis.
• Bone mineral density (BMD) was measured 2-3 times over 17.5 months using dual energy x-ray absorptiometry at the lumbar spine, hip, and whole body.
• Participants were categorized based on luteal phase abnormalities (anovulatory or short luteal phase cycles) and compared to women with normal cycles.

Main Results:

• No significant difference in baseline BMD was observed between women with luteal abnormalities and those with normal cycles.
• Women with luteal abnormalities showed no significant accelerated bone loss at the spine or hip compared to controls.
• A trend towards whole-body BMD loss was noted in women with luteal abnormalities, but the magnitude was not unusual for the age group.

Conclusions:

• The study did not confirm a relationship between luteal phase abnormalities and accelerated bone mineral density loss in healthy premenopausal women.
• Menstrual cycle regularity and luteal phase length were not associated with baseline BMD or annual BMD change.
• Further research may be needed to explore other factors influencing bone health in women with menstrual irregularities.